Enovis™ (NYSE: ENOV) is spotlighting its commitment to advancing foot and ankle surgery at the American College of Foot & ...

Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary PerforationsWAYNE, Pa., March 27, 2025 ...

Splenic abnormalities usually present as a focal lesion(s) or diffuse splenomegaly outside the context of trauma. Most ...

Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for ...

Teleflex (TFX) announced that the preliminary results from its Ringer PBC IDE study were reported in a featured presentation at the CTO Plus ...

Recent study focused on comparing the effectiveness of ultrasound-guided percutaneous cryoneurolysis to intercostal nerve ...

Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million.

US-based Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position ...

In an attempt to reduce ischemic events during and after percutaneous coronary intervention (PCI), an intensive antiplatelet and anticoagulant regimen has been adopted. The trade-off of this ...

Endologix LLC announced it has reached a milestone of 1,000 patients who have been treated with percutaneous transmural ...